HEADER PEPTIDE BINDING PROTEIN 14-SEP-00 1FU5 TITLE NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3- TITLE 2 KINASE COMPLEXED TO A DOUBLY PHOSPHORYLATED PEPTIDE TITLE 3 DERIVED FROM POLYOMAVIRUS MIDDLE T ANTIGEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA COMPND 3 SUBUNIT; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: RESIDUES 321 TO 431 OF P85, N-SH2 (SRC HOMOLOGY COMPND 6 2) DOMAIN; COMPND 7 SYNONYM: PI3-KINASE P85-ALPHA SUBUNIT, PTDINS-3-KINASE P85- COMPND 8 ALPHA, PI3K; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: DOUBLY PHOSPHORYLATED MIDDLE T ANTIGEN; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: RESIDUES 312 TO 326 OF MT ANTIGEN, Y315 AND Y322 COMPND 14 PHOSPHORYLATED; COMPND 15 SYNONYM: MT PEPTIDE; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 OTHER_DETAILS: MT PEPTIDE WAS SYNTHESIZED BY THE TUFTS SOURCE 10 PROTEIN CHEMISTRY FACILITY KEYWDS PROTEIN-PEPTIDE COMPLEX, PEPTIDE BINDING PROTEIN EXPDTA SOLUTION NMR AUTHOR T.WEBER,B.SCHAFFHAUSEN,Y.LIU,U.L.GUENTHER REVDAT 3 24-FEB-09 1FU5 1 VERSN REVDAT 2 01-APR-03 1FU5 1 JRNL REVDAT 1 21-FEB-01 1FU5 0 JRNL AUTH T.WEBER,B.SCHAFFHAUSEN,Y.LIU,U.L.GUNTHER JRNL TITL NMR STRUCTURE OF THE N-SH2 OF THE P85 SUBUNIT OF JRNL TITL 2 PHOSPHOINOSITIDE 3-KINASE COMPLEXED TO A DOUBLY JRNL TITL 3 PHOSPHORYLATED PEPTIDE REVEALS A SECOND JRNL TITL 4 PHOSPHOTYROSINE BINDING SITE. JRNL REF BIOCHEMISTRY V. 39 15860 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 11123912 JRNL DOI 10.1021/BI001474D REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER REMARK 3 AUTHORS : MSI REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WITH THE LOWEST ENERGY REMARK 3 IS PRESENTED REMARK 4 REMARK 4 1FU5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-00. REMARK 100 THE RCSB ID CODE IS RCSB011903. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 305 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 0.1MM REMARK 210 PRESSURE : 1 BAR REMARK 210 SAMPLE CONTENTS : 0.15MM N-SH2 15N, 13C; MT REMARK 210 PEPTIDE; 0.1MM KCL; 95% H2O, REMARK 210 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, 3D_13C-SEPARATED_ REMARK 210 NOESY, 3D_15N-SEPARATED_NOESY, REMARK 210 13C{F1}-FILTERED 2D-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ, 600 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRLAB, PRONTO, NMR2ST, DYANA REMARK 210 METHOD USED : THE STRUCTURES WERE ENERGY REMARK 210 MINIMIZED WITH MSI DISCOVER. REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 110 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH FAVORABLE NON REMARK 210 -BOND ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NOESY ASSIGNMENTS WERE OBTAINED BY A SEMI-AUTOMATIC REMARK 210 PROCEDURE EMPLOYING A PROGRAM FROM PRISTOVSEK [PRISTOVSEK, P. REMARK 210 & KIDRIC, J. (1997) BIOPOL. 42, 671-679)]. INITIAL REMARK 210 CALCULATIONS INCLUDED ONLY INTRAMOLECULAR CONSTRAINTS. THE REMARK 210 OBSERVED NOES DERIVED FROM 13C{F1}-FILTERED 2D-NOESY SPECTRA REMARK 210 WERE INCORPORATED INTO THE STRUCTURE CALCULATION WHEN THE REMARK 210 PROTEIN FOLD WAS ALREADY CORRECT. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU B 15 C LEU B 15 OXT 0.151 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 87.69 58.86 REMARK 500 MET A 6 139.89 -179.89 REMARK 500 SER A 7 154.39 62.20 REMARK 500 GLN A 9 40.07 34.23 REMARK 500 ASP A 10 31.83 -159.73 REMARK 500 GLU A 12 -73.92 65.24 REMARK 500 TYR A 14 34.40 -87.84 REMARK 500 ASP A 17 108.25 52.00 REMARK 500 SER A 19 103.52 76.53 REMARK 500 ARG A 20 -70.27 -30.12 REMARK 500 ASP A 29 39.58 175.70 REMARK 500 THR A 30 -77.66 -55.68 REMARK 500 THR A 34 45.72 -82.27 REMARK 500 PHE A 35 163.63 -42.98 REMARK 500 LEU A 36 155.86 177.95 REMARK 500 ARG A 38 -44.29 -137.31 REMARK 500 ASP A 39 147.06 57.01 REMARK 500 ALA A 40 -138.79 -177.42 REMARK 500 THR A 42 89.14 -54.68 REMARK 500 HIS A 45 71.35 -101.53 REMARK 500 TYR A 48 28.77 -158.95 REMARK 500 THR A 49 -176.16 47.82 REMARK 500 LEU A 50 145.00 178.90 REMARK 500 ASN A 58 119.69 60.90 REMARK 500 SER A 60 -47.41 168.91 REMARK 500 ILE A 61 141.32 57.27 REMARK 500 LYS A 62 143.71 174.57 REMARK 500 ARG A 66 -85.01 -138.93 REMARK 500 ASP A 67 61.81 -100.04 REMARK 500 TYR A 70 -165.98 -53.87 REMARK 500 PHE A 72 -31.83 -36.50 REMARK 500 ASP A 74 86.70 61.83 REMARK 500 THR A 77 44.96 152.61 REMARK 500 VAL A 81 38.51 -90.69 REMARK 500 ASN A 90 116.95 151.18 REMARK 500 GLU A 91 -18.51 154.99 REMARK 500 SER A 92 160.90 89.48 REMARK 500 ALA A 94 64.20 -65.37 REMARK 500 GLN A 95 -84.37 -66.53 REMARK 500 ASN A 97 148.35 -178.70 REMARK 500 PRO A 98 48.19 -75.00 REMARK 500 LEU A 100 -76.80 -125.30 REMARK 500 ASP A 101 66.06 30.35 REMARK 500 LYS A 103 164.55 78.26 REMARK 500 LEU A 104 27.24 -160.29 REMARK 500 LYS A 110 93.25 46.20 REMARK 500 MET B 7 152.39 169.34 REMARK 500 GLU B 8 -99.29 174.66 REMARK 500 ASP B 9 126.14 73.44 REMARK 500 ASP B 13 -165.34 43.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FU6 RELATED DB: PDB REMARK 900 1FU6 IS NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 REMARK 900 SUBUNIT OF PI3-KINASE DBREF 1FU5 A 1 111 UNP Q63787 P85A_RAT 321 431 DBREF 1FU5 B 1 15 UNP P03076 TAMI_POVM3 331 345 SEQADV 1FU5 SER A 60 UNP Q63787 LEU 380 CONFLICT SEQADV 1FU5 PTR B 4 UNP P03076 TYR 334 MODIFIED RESIDUE SEQADV 1FU5 PTR B 11 UNP P03076 TYR 341 MODIFIED RESIDUE SEQRES 1 A 111 GLY MET ASN ASN ASN MET SER LEU GLN ASP ALA GLU TRP SEQRES 2 A 111 TYR TRP GLY ASP ILE SER ARG GLU GLU VAL ASN GLU LYS SEQRES 3 A 111 LEU ARG ASP THR ALA ASP GLY THR PHE LEU VAL ARG ASP SEQRES 4 A 111 ALA SER THR LYS MET HIS GLY ASP TYR THR LEU THR LEU SEQRES 5 A 111 ARG LYS GLY GLY ASN ASN LYS SER ILE LYS ILE PHE HIS SEQRES 6 A 111 ARG ASP GLY LYS TYR GLY PHE SER ASP PRO LEU THR PHE SEQRES 7 A 111 ASN SER VAL VAL GLU LEU ILE ASN HIS TYR ARG ASN GLU SEQRES 8 A 111 SER LEU ALA GLN TYR ASN PRO LYS LEU ASP VAL LYS LEU SEQRES 9 A 111 LEU TYR PRO VAL SER LYS TYR SEQRES 1 B 15 GLU GLU GLU PTR MET PRO MET GLU ASP LEU PTR LEU ASP SEQRES 2 B 15 ILE LEU MODRES 1FU5 PTR B 4 TYR O-PHOSPHOTYROSINE MODRES 1FU5 PTR B 11 TYR O-PHOSPHOTYROSINE HET PTR B 4 25 HET PTR B 11 25 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR 2(C9 H12 N O6 P) HELIX 1 1 SER A 19 LEU A 27 1 9 HELIX 2 2 VAL A 82 TYR A 88 1 7 LINK C GLU B 3 N PTR B 4 1555 1555 1.33 LINK C PTR B 4 N MET B 5 1555 1555 1.32 LINK C LEU B 10 N PTR B 11 1555 1555 1.33 LINK C PTR B 11 N LEU B 12 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 149 0 2 2 0 0 0 6 0 0 0 11 END